دورية أكاديمية
أعرض في EDS

Use of inactivated poliovirus vaccine for poliovirus outbreak response.

التفاصيل البيبلوغرافية
العنوان: Use of inactivated poliovirus vaccine for poliovirus outbreak response.
المؤلفون: Bandyopadhyay AS; Bill & Melinda Gates Foundation, Seattle, WA, USA. Electronic address: ananda.bandyopadhyay@gatesfoundation.org., Lopez Cavestany R; Polio Eradication Department, World Health Organization, Geneva, Switzerland., Blake IM; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK., Macklin G; Polio Eradication Department, World Health Organization, Geneva, Switzerland., Cooper L; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK., Grassly N; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK., Nery ALMDS; Bill & Melinda Gates Foundation, Seattle, WA, USA., Mach O; Polio Eradication Department, World Health Organization, Geneva, Switzerland.
المصدر: The Lancet. Infectious diseases [Lancet Infect Dis] 2024 May; Vol. 24 (5), pp. e328-e342. Date of Electronic Publication: 2023 Nov 25.
نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE
أسماء مطبوعة: Original Publication: New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-
مواضيع طبية MeSH: Poliomyelitis*/prevention & control , Poliomyelitis*/epidemiology , Disease Outbreaks*/prevention & control , Poliovirus Vaccine, Inactivated*/administration & dosage , Poliovirus Vaccine, Inactivated*/immunology , Poliovirus*/immunology, Humans ; Poliovirus Vaccine, Oral/administration & dosage ; Poliovirus Vaccine, Oral/immunology ; Global Health ; Disease Eradication
مستخلص: With continued wild poliovirus transmission in Afghanistan and Pakistan and circulating vaccine-derived poliovirus in certain countries, there exists an ongoing risk of importation of polioviruses into other countries, including those that have been polio-free for decades. Diversifying the poliovirus outbreak response toolkit is essential to account for different public health and epidemiological contexts. In this Personal View, we discuss data on intestinal and pharyngeal mucosal immunity induced by inactivated poliovirus vaccine (IPV), previous programmatic experience of poliovirus outbreak response with IPV, and outbreak response guidelines in countries that exclusively use IPV. With recent reports of poliovirus detection in polio-free countries such as the USA and the UK, it is important to assess the interplay of virus transmission dynamics, vaccine impact on preventing paralysis and virus spread, and regulatory complexities of using oral poliovirus vaccine (OPV) and IPV options for outbreak response. As the global eradication programme navigates through cessation of routine OPV use with replacement by IPV and stockpiling of novel OPVs, clarity on the impact of IPV use will be important for informed decision making by global, regional, and national policy makers.
Competing Interests: Declaration of interests We declare no competing interests.
(Copyright © 2024 Elsevier Ltd. All rights reserved.)
التعليقات: Erratum in: Lancet Infect Dis. 2024 Feb;24(2):e83. (PMID: 38070529)
معلومات مُعتمدة: 001 International WHO_ World Health Organization
المشرفين على المادة: 0 (Poliovirus Vaccine, Inactivated)
0 (Poliovirus Vaccine, Oral)
تواريخ الأحداث: Date Created: 20231128 Date Completed: 20240426 Latest Revision: 20240427
رمز التحديث: 20240428
DOI: 10.1016/S1473-3099(23)00505-4
PMID: 38012892
قاعدة البيانات: MEDLINE
الوصف
تدمد:1474-4457
DOI:10.1016/S1473-3099(23)00505-4